ResearchA Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer
ResearchSummary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer
ResearchEditorial Comment on "Muscle-Invasive Bladder Cancer Treatment Selection in an Emerging Treatment Era: A Patient Preference Study"
ResearchClinical Trial in Progress: SWOG S2210, a Phase 2 Study of Neoadjuvant Carboplatin for Localized High-risk Prostate Cancer with Germline BRCA1/2 Mutations
ResearchCompliance With Intravesical Bacillus Calmette-Guérin Therapy for Nonmuscle-Invasive Bladder Cancer
ResearchImpact of rural location on receipt of standard of care treatment and survival for locally advanced bladder cancer in Louisiana
ResearchPerioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study
ResearchEnsuring Successful Biomarker Studies in Bladder Preservation Clinical Trials for Non-muscle Invasive Bladder Cancer
ResearchSimple and Epididymal-Sparing Orchiectomy for Surgical Castration in Stage IV Prostate Cancer
ResearchDoes Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?
ResearchSurgical challenges and considerations in Tri-modal therapy for muscle invasive bladder cancer